Skip to main content
. 2020 Jan 19;22(4):673–677. doi: 10.1111/jch.13808

Table 1.

Clinical characteristics of PAMELA participants classified according to their blood pressure (BP) status in normotensive (ie, normal office, ambulatory, and home BP), dual masked hypertension (ie, MH normal office, elevated home, and ambulatory BP), isolated ambulatory MH (ie, normal office and home, and elevated ambulatory BP) and isolated home MH (ie, normal office, elevated home, and normal ambulatory BP)

Variables

Normotensive

N = 894

Dual MH

N = 48

Isolated Ambulatory

MH

N = 62

Isolated Home MH

N = 83
Male, % 42.51a, b, c 70.83 70.97 62.65
Age, years 44 ± 12.1a, c 52.8 ± 11.5b 46.2 ± 10.8c 53.7 ± 14.5
BMI, kg/m2 24 ± 3.6a, c 27.1 ± 3.8 25.1 ± 3.4 25.8 ± 3.5
Office SBP, mm Hg 117.7 ± 10.3a, b, c 127.7 ± 7.8 124.8 ± 7.5 125.6 ± 8.4
Office DBP, mm Hg 76.8 ± 7a, b, c 82.6 ± 4.5c 82.6 ± 5.3c 79.4 ± 5.2
24 h SBP, mm Hg 112.9 ± 7a, b, c 130.5 ± 6.9a, c 126.8 ± 5.3c 118.2 ± 6.2
24 h DBP, mm Hg 70.3 ± 5a, b, c 82.2 ± 4.7c 81.6 ± 3.3c 72.4 ± 4.5
Home SBP, mm Hg 111.6 ± 10.8a, b, c 138.4 ± 12.2b 121.2 ± 8.2c 136.9 ± 13.3
Home DBP, mm Hg 69.9 ± 7.1a, b, c 86.5 ± 5.5b 77.3 ± 4.8c 85 ± 12.2
Serum glucose mg/dL 85.8 ± 12.4a, b 105.3 ± 52.9b, c 92.3 ± 26.3 87.9 ± 14.4
Serum total cholesterol, mg/dL 214.1 ± 41.1a, c 231.4 ± 45.3 221.1 ± 41.7 230.4 ± 46.2
Serum HDL cholesterol, mg/dL 57.5 ± 15.7 54.6 ± 18 52.4 ± 13.7 53.2 ± 15.5
Creatinine, mg/dL 0.85 ± 0.15c 0.86 ± 0.14 0.91 ± 0.15 0.94 ± 0.31
LVMI, g/m2 77.7 ± 16.4a, b, c 87.8 ± 17.4 85.6 ± 19.0 88 ± 17.1
Prevalence of MS, % 4.9a 18.7 9.8 12.3
LVMI >114/99 g/m2, % 4.6a, b, c 8.7 8.6 10.6
Antihypertensive treatment, % 4.82c 6.25c 8.06c 25.30
Type 2 Diabetes (%) 3.1 3.9 3.5 4.0
Current Smoking (%) 22.1c 18.0 19.7 16.1

As for differences in LVMI and prevalence of LVH data are adjusted for age, sex and BMI, glycemia, total cholesterol, serum creatinine, smoking, and antihypertensive treatment.

Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; LVMI, left ventricular mass index, MS, metabolic syndrome; SBP, systolic blood pressure.

a

P < .05 vs dual MH.

b

P < .05 vs isolated ambulatory MH.

c

P < .05 vs isolated home MH.